Skip to content

Magdalena Bujalska-Zadrozny

2 papers in the library · 14 citations · publishing 2016-2023

Papers

Reasons, Form of Ingestion and Side Effects Associated with Consumption of Amanita muscaria.

Toxics April 17, 2023 Michal Ordak, Aleksandra Galazka, Tadeusz Nasierowski et al. 14 citations

A new trend of consuming Amanita muscaria is analyzed through social media comments. Among 684 people, women mainly used the mushroom to reduce pain and skin problems, while men used it to relieve stress, depressive symptoms, and insomnia. Women predominantly consumed tinctures, whereas men used dried forms. Side effects differed by gender: women reported headaches, men reported nausea, vomiting, abdominal pain, and drowsiness. The authors call for advanced research to raise awareness of the fungus's toxicity.

Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Neurotoxicity research November 1, 2016 Patrycja Kleczkowska, Irena Smaga, Malgorzata Filip et al.

Cannabinoids, despite their illegal status, have recognized therapeutic potential and are often used recreationally by young adults, sometimes as an alternative to other drugs or to enhance pleasure. They are frequently taken alongside medications for alcohol use disorder (AUD) and alcohol withdrawal syndrome (AWS), such as disulfiram, acamprosate, and naltrexone. This paper reviews recent findings on possible beneficial effects and interactions between cannabinoids and these AUD/AWS medications, whether the conditions are comorbid or separate.